Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial - PubMed (original) (raw)

Randomized Controlled Trial

. 2018 Jun;268(4):321-335.

doi: 10.1007/s00406-018-0868-4. Epub 2018 Jan 22.

Affiliations

• PMID: 29356899
• DOI: 10.1007/s00406-018-0868-4

Randomized Controlled Trial

Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial

E Hoxhaj et al. Eur Arch Psychiatry Clin Neurosci. 2018 Jun.

Abstract

Background: Mindfulness training is a promising treatment approach in adult ADHD. However, there has not yet been a randomized controlled trial comparing mindfulness to an active control condition. In this study, we assessed the efficacy of a mindfulness training program (MAP) compared to structured psychoeducation (PE).

Methods: After randomization 81 medication-free adult ADHD patients participated either in an 8-week MAP or PE group program. At baseline (T1), after 8 weeks (T2) and after 8 months (T3), severity of ADHD and associated symptoms (depression, general psychopathology, quality of life) were measured with the Conner's ADHD Rating Scales (CAARS), the Beck Depression Inventory (BDI), the Brief Symptom Inventory (BSI) and the SF-36 by self and blind observer ratings.

Results: Both groups showed significant pre-post improvements in observer-rated Inattention scale (p < .001, partial η2 = 0.18) and in associated symptomatology, which persisted through 6 months of follow-up. There were no significant differences regarding symptom reduction between the treatment groups. Women benefited more compared to men irrespective of treatment group. Men showed the most pronounced changes under MAP.

Conclusions: In the current study, MAP was not superior to PE regarding symptom reduction in adult ADHD. Both interventions, mindfulness meditation and PE, were efficacious in reducing symptom load in adult ADHD. Furthermore in exploratory post hoc tests the study provides evidence for a potential gender-specific treatment response in adult ADHD.

Keywords: Adult ADHD; Gender; Mindfulness; Psychoeducation; Psychotherapy.

PubMed Disclaimer

Similar articles

• Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial.
  Durell TM, Adler LA, Williams DW, Deldar A, McGough JJ, Glaser PE, Rubin RL, Pigott TA, Sarkis EH, Fox BK. Durell TM, et al. J Clin Psychopharmacol. 2013 Feb;33(1):45-54. doi: 10.1097/JCP.0b013e31827d8a23. J Clin Psychopharmacol. 2013. PMID: 23277268 Clinical Trial.
• Atomoxetine Increased Effect over Time in Adults with Attention-Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double-Blind, Placebo-Controlled, Randomized Trials.
  Wietecha LA, Clemow DB, Buchanan AS, Young JL, Sarkis EH, Findling RL. Wietecha LA, et al. CNS Neurosci Ther. 2016 Jul;22(7):546-57. doi: 10.1111/cns.12533. Epub 2016 Feb 28. CNS Neurosci Ther. 2016. PMID: 26922462 Free PMC article.
• Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder.
  Walker DJ, Mason O, Clemow DB, Day KA. Walker DJ, et al. Postgrad Med. 2015;127(7):686-701. doi: 10.1080/00325481.2015.1081046. Postgrad Med. 2015. PMID: 26343377 Review.
• Atomoxetine treatment for children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD): a comprehensive meta-analysis of outcomes on parent-rated core symptomatology.
  Gayleard JL, Mychailyszyn MP. Gayleard JL, et al. Atten Defic Hyperact Disord. 2017 Sep;9(3):149-160. doi: 10.1007/s12402-017-0216-y. Epub 2017 Jan 21. Atten Defic Hyperact Disord. 2017. PMID: 28110366 Review.

Cited by

• Systematic Review for the Medical Applications of Meditation in Randomized Controlled Trials.
  Kim DY, Hong SH, Jang SH, Park SH, Noh JH, Seok JM, Jo HJ, Son CG, Lee EJ. Kim DY, et al. Int J Environ Res Public Health. 2022 Jan 22;19(3):1244. doi: 10.3390/ijerph19031244. Int J Environ Res Public Health. 2022. PMID: 35162267 Free PMC article. Review.
• Psychoeducation for adult ADHD: a scoping review about characteristics, patient involvement, and content.
  Pedersen H, Skliarova T, Pedersen SA, Gråwe RW, Havnen A, Lara-Cabrera ML. Pedersen H, et al. BMC Psychiatry. 2024 Jan 25;24(1):73. doi: 10.1186/s12888-024-05530-8. BMC Psychiatry. 2024. PMID: 38273266 Free PMC article.
• Short report: A co-designed psychoeducation for older autistic adults-a multiple case study.
  Groenendijk ER, Van Heijst B, Geurts HM. Groenendijk ER, et al. Autism. 2023 May;27(4):1163-1169. doi: 10.1177/13623613221138691. Epub 2022 Dec 15. Autism. 2023. PMID: 36519752 Free PMC article.
• Hyperactivity/restlessness is associated with increased functional connectivity in adults with ADHD: a dimensional analysis of resting state fMRI.
  Sörös P, Hoxhaj E, Borel P, Sadohara C, Feige B, Matthies S, Müller HHO, Bachmann K, Schulze M, Philipsen A. Sörös P, et al. BMC Psychiatry. 2019 Jan 25;19(1):43. doi: 10.1186/s12888-019-2031-9. BMC Psychiatry. 2019. PMID: 30683074 Free PMC article. Clinical Trial.
• Chatbot-supported psychoeducation in adult attention-deficit hyperactivity disorder: randomised controlled trial.
  Selaskowski B, Reiland M, Schulze M, Aslan B, Kannen K, Wiebe A, Wallbaum T, Boll S, Lux S, Philipsen A, Braun N. Selaskowski B, et al. BJPsych Open. 2023 Oct 13;9(6):e192. doi: 10.1192/bjo.2023.573. BJPsych Open. 2023. PMID: 37827996 Free PMC article.

References

1. 1. Clin Neurophysiol. 2014 Jul;125(7):1407-16 - PubMed
2. 1. J Nerv Ment Dis. 2007 Dec;195(12):1013-9 - PubMed
3. 1. Assessment. 2008 Sep;15(3):329-42 - PubMed
4. 1. Front Psychiatry. 2016 Jun 27;7:117 - PubMed
5. 1. Psychiatry Res. 2011 May 30;187(3):441-53 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information